EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Survival risk factors in T1G3 non-muscle-invasive (NMI) bladder cancer consevatively treated. Long term results.

Serretta, V.
Allegro, R.
Ruggirello, A.
Coraci, G.
DI DIO, M.
PAVONE MACALUSO, M.
Aragona, F.
Melloni, D.

January 2008

Introduction: The most relevant risk factor in T1G3 NMI transitional cell carcinoma of the bladder ...

Survival risk factors in T1G3 non-muscle-invasive (NMI) bladder cancer consevatively treated. Long term results.

SERRETTA, Vincenzo
ALLEGRO, Rosalinda
CORACI, Giuseppe
DI DIO, Michele
MELLONI, Darvinio
RUGGIRELLO A
PAVONE MACALUSO M
ARAGONA F

January 2008

Introduction: The most relevant risk factor in T1G3 NMI transitional cell carcinoma of the bladder...

Prognostic factors and risk groups in T1G3 non-muscle invasive bladder cancer patients initially treated with Bacillus Calmette Guerin results of a retrospective multi center study on 2451 patients

Gontero P
Sylvester R
Pisano F
Joniau S
Vander Eeckt K
Serretta V
Larré S
Di Stasi S
Van Rhijn B
Witjes AJ
Grotenhuis AJ
Kiemeney LA
Colombo R
Briganti A
Babjuk M
Malmström PU
Oderda M
Irani J
Malats N
Baniel J
Mano R
Cai T
Cha EK
Ardelt P
Varkarakis J
BARTOLETTI, RICCARDO
Spahn M
Johansson R
Frea B
Soukup V
Xylinas E
Dalbagni G
Karnes RJ
Shariat SF
Palou J.

January 2015

The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critic...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Turkeri, Levent
Collette, Sandra
Cambier, Samantha
Sylvester, Richard J.
Collette, Laurence
Gontero, Paolo
Brausi, Maurizio A.
van Andel, George
Kirkels, Wim J.
Da Silva, Fernando Calais
Oosterlinck, Willem
Prescott, Stephen
Kirkali, Ziya
Oddens, Jorg
Powell, Philip H.
de Reijke, Theo M.

January 2016

Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder c...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Cambier, S
Sylvester, RJ
Collette, L
Gontero, P
Brausi, MA
van Andel, G
Kirkels, Wim
Da Silva, FC
Oosterlinck, W
Prescott, S
Kirkali, Z
Powell, PH
de Reijke, TM
Turkeri, L
Collette, S
Oddens, J

January 2016

Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder c...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

Cambier, Samantha
Sylvester, Richard J
Collette, Laurence
Gontero, Paolo
Brausi, Maurizio A
van Andel, George
Kirkels, Wim J
Silva, Fernando Calais Da
Oosterlinck, Willem
Prescott, Stephen
Kirkali, Ziya
Powell, Philip H
de Reijke, Theo M
Turkeri, Levent
Collette, Sandra
Oddens, Jorg

January 2016

Background There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder ca...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin

Cambier, Samantha
Sylvester, Richard J.
Collette, Laurence
Gontero, Paolo
Brausi, Maurizio A.
van Andel, George
Kirkels, Wim J.
Silva, Fernando Calais Da
Oosterlinck, Willem
Prescott, Stephen
Kirkali, Ziya
Powell, Philip H.
de Reijke, Theo M.
Turkeri, Levent
Collette, Sandra
Oddens, Jorg

January 2016

There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder cancer (NMIBC...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin

Cambier, S
Sylvester, RJ
Collette, L
Gontero, P
Brausi, MA
van Andel, G
Kirkels, WJ
Calais da Silva, F
Oosterlinck, W
Prescott, S
Kirkali, Z
Powell, PH
de Reijke, TM
Turkeri, L
Collette, S
Oddens, J

January 2016

BACKGROUND: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin

Cambier, S
Sylvester, RJ
Collette, L
Gontero, P
Brausi, MA
van Andel, G
Kirkels, WJ
Calais da Silva, F
Oosterlinck, W
Prescott, S
Kirkali, Z
Powell, PH
de Reijke, TM
Turkeri, L
Collette, S
Oddens, J

January 2016

BACKGROUND: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder...

Risk factor assessment in high-risk, bacillus calmette–guérin-treated, non-muscle-invasive bladder cancer

Holz, Serge
Albisinni, Simone
Gilsoul, Jacques
Pirson, Michel
Duthie, Veronique
Quackels, Thierry
Vanden Bossche, Marc
Roumeguere, Thierry

September 2017

Objective: To assess the risk factors associated with recurrence, progression and survival in high-r...

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.

Alkhateeb, Sultan
Neill, Mischel
Bar-Moshe, Sas
Rhijn, Bas Van
Kakiashvili, David M
Fleshner, Neil E.
Jewett, Michael A.S.
Petein, Michel
Schulman, Claude
Hanna, Sally
Bostrom, Peter J
Roumeguere, Thierry
Shariat, Shahrokh F.
Rorive, Sandrine
Zlotta, Alexandre

September 2011

To evaluate the long-term prognostic value of the combination of the EORTC risk calculator and proap...

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients

Gontero, Paolo
Sylvester, Richard
Pisano, Francesca
Joniau, Steven
Vander Eeckt, Kathy
Serretta, Vincenzo
Larré, Stéphane
Di Stasi, Savino
Van Rhijn, Bas
Witjes, Alfred J
Grotenhuis, Anne J
Kiemeney, Lambertus A
Colombo, Renzo
Briganti, Alberto
Babjuk, Marek
Malmström, Per-Uno
Oderda, Marco
Irani, Jacques
Malats, Nuria
Baniel, Jack
Mano, Roy
Cai, Tommaso
Cha, Eugene K
Ardelt, Peter
Varkarakis, John
Bartoletti, Riccardo
Spahn, Martin
Johansson, Robert
Frea, Bruno
Soukup, Viktor
Xylinas, Evanguelos
Dalbagni, Guido
Karnes, R Jeffrey
Shariat, Shahrokh F
Palou, Joan

January 2015

The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critic...

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients

Gontero, P.
Sylvester, R.
Pisano, F.
Joniau, S.
Vander Eeckt, K.
Serretta, V.
Larré, S.
Di Stasi, S.
Van Rhijn, B.
Witjes, Aj
Grotenhuis, Aj
Kiemeney, La
Colombo, R.
Briganti, A.
Babjuk, M.
Malmström, Pu
Oderda, Marco
Irani, J.
Malats, N.
Baniel, J.
Mano, R.
Cai, T.
Cha, Ek
Ardelt, P.
Varkarakis, J.
Bartoletti, R.
Spahn, M.
Johansson, R.
Frea, B.
Soukup, V.
Xylinas, E.
Dalbagni, G.
Karnes, Rj
Shariat, Sf
Palou, J.

January 2015

BACKGROUND: The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patien...

Prognostic Factors and Risk Groups in T1G3 Non\u2013Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Gue\ub4 rin: Results of a retrospective Multicenter Study of 2451 Patients

Gontero, P
Sylvester, R
Pisano, F
Joniau, S
Eeckt, KV
Serretta, V
Larr\ue9, S
Di Stasi, S
Van Rhijn g, B
Witjes, AJ
Grotenhuis, AJ
Kiemeney, LA
Colombo, R
Alberto Briganti, A
Babjuk , M
Malmstrom, PU
, Oderda, M
Irani, J
Nuria Malats, N
Baniel, J
Mano, R
Cai, T
Cha, EK
Ardelt, P
Varkarakis, J
Bartoletti, R
Spahn, M
Johansson, R
Frea , B
Soukup, V
Xylinas, E
Dalbagni, G
Karnes RJ
Shariat SF
, Palou, J

January 2015

Background: The impact of prognostic factors in T1G3 non\u2013muscle-invasive bladder cancer (BCa) p...

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Joseph Plasek
John Weissert
Tracy Downs
Kyle Richards
Kourosh Ravvaz

June 2021

BackgroundBacillus Calmette-Guérin (BCG) is currently the most clinically effective intravesical tre...

Survival risk factors in T1G3 non-muscle-invasive (NMI) bladder cancer consevatively treated. Long term results.

Serretta, V.
Allegro, R.
Ruggirello, A.
Coraci, G.
DI DIO, M.
PAVONE MACALUSO, M.
Aragona, F.
Melloni, D.

January 2008

Introduction: The most relevant risk factor in T1G3 NMI transitional cell carcinoma of the bladder ...

Survival risk factors in T1G3 non-muscle-invasive (NMI) bladder cancer consevatively treated. Long term results.

SERRETTA, Vincenzo
ALLEGRO, Rosalinda
CORACI, Giuseppe
DI DIO, Michele
MELLONI, Darvinio
RUGGIRELLO A
PAVONE MACALUSO M
ARAGONA F

January 2008

Introduction: The most relevant risk factor in T1G3 NMI transitional cell carcinoma of the bladder...

Prognostic factors and risk groups in T1G3 non-muscle invasive bladder cancer patients initially treated with Bacillus Calmette Guerin results of a retrospective multi center study on 2451 patients

Gontero P
Sylvester R
Pisano F
Joniau S
Vander Eeckt K
Serretta V
Larré S
Di Stasi S
Van Rhijn B
Witjes AJ
Grotenhuis AJ
Kiemeney LA
Colombo R
Briganti A
Babjuk M
Malmström PU
Oderda M
Irani J
Malats N
Baniel J
Mano R
Cai T
Cha EK
Ardelt P
Varkarakis J
BARTOLETTI, RICCARDO
Spahn M
Johansson R
Frea B
Soukup V
Xylinas E
Dalbagni G
Karnes RJ
Shariat SF
Palou J.

January 2015

The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critic...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Turkeri, Levent
Collette, Sandra
Cambier, Samantha
Sylvester, Richard J.
Collette, Laurence
Gontero, Paolo
Brausi, Maurizio A.
van Andel, George
Kirkels, Wim J.
Da Silva, Fernando Calais
Oosterlinck, Willem
Prescott, Stephen
Kirkali, Ziya
Oddens, Jorg
Powell, Philip H.
de Reijke, Theo M.

January 2016

Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder c...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Cambier, S
Sylvester, RJ
Collette, L
Gontero, P
Brausi, MA
van Andel, G
Kirkels, Wim
Da Silva, FC
Oosterlinck, W
Prescott, S
Kirkali, Z
Powell, PH
de Reijke, TM
Turkeri, L
Collette, S
Oddens, J

January 2016

Background: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder c...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

Cambier, Samantha
Sylvester, Richard J
Collette, Laurence
Gontero, Paolo
Brausi, Maurizio A
van Andel, George
Kirkels, Wim J
Silva, Fernando Calais Da
Oosterlinck, Willem
Prescott, Stephen
Kirkali, Ziya
Powell, Philip H
de Reijke, Theo M
Turkeri, Levent
Collette, Sandra
Oddens, Jorg

January 2016

Background There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder ca...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin

Cambier, Samantha
Sylvester, Richard J.
Collette, Laurence
Gontero, Paolo
Brausi, Maurizio A.
van Andel, George
Kirkels, Wim J.
Silva, Fernando Calais Da
Oosterlinck, Willem
Prescott, Stephen
Kirkali, Ziya
Powell, Philip H.
de Reijke, Theo M.
Turkeri, Levent
Collette, Sandra
Oddens, Jorg

January 2016

There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder cancer (NMIBC...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin

Cambier, S
Sylvester, RJ
Collette, L
Gontero, P
Brausi, MA
van Andel, G
Kirkels, WJ
Calais da Silva, F
Oosterlinck, W
Prescott, S
Kirkali, Z
Powell, PH
de Reijke, TM
Turkeri, L
Collette, S
Oddens, J

January 2016

BACKGROUND: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin

Cambier, S
Sylvester, RJ
Collette, L
Gontero, P
Brausi, MA
van Andel, G
Kirkels, WJ
Calais da Silva, F
Oosterlinck, W
Prescott, S
Kirkali, Z
Powell, PH
de Reijke, TM
Turkeri, L
Collette, S
Oddens, J

January 2016

BACKGROUND: There are no prognostic factor publications on stage Ta-T1 non-muscle-invasive bladder...

Risk factor assessment in high-risk, bacillus calmette–guérin-treated, non-muscle-invasive bladder cancer

Holz, Serge
Albisinni, Simone
Gilsoul, Jacques
Pirson, Michel
Duthie, Veronique
Quackels, Thierry
Vanden Bossche, Marc
Roumeguere, Thierry

September 2017

Objective: To assess the risk factors associated with recurrence, progression and survival in high-r...

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.

Alkhateeb, Sultan
Neill, Mischel
Bar-Moshe, Sas
Rhijn, Bas Van
Kakiashvili, David M
Fleshner, Neil E.
Jewett, Michael A.S.
Petein, Michel
Schulman, Claude
Hanna, Sally
Bostrom, Peter J
Roumeguere, Thierry
Shariat, Shahrokh F.
Rorive, Sandrine
Zlotta, Alexandre

September 2011

To evaluate the long-term prognostic value of the combination of the EORTC risk calculator and proap...

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients

Gontero, Paolo
Sylvester, Richard
Pisano, Francesca
Joniau, Steven
Vander Eeckt, Kathy
Serretta, Vincenzo
Larré, Stéphane
Di Stasi, Savino
Van Rhijn, Bas
Witjes, Alfred J
Grotenhuis, Anne J
Kiemeney, Lambertus A
Colombo, Renzo
Briganti, Alberto
Babjuk, Marek
Malmström, Per-Uno
Oderda, Marco
Irani, Jacques
Malats, Nuria
Baniel, Jack
Mano, Roy
Cai, Tommaso
Cha, Eugene K
Ardelt, Peter
Varkarakis, John
Bartoletti, Riccardo
Spahn, Martin
Johansson, Robert
Frea, Bruno
Soukup, Viktor
Xylinas, Evanguelos
Dalbagni, Guido
Karnes, R Jeffrey
Shariat, Shahrokh F
Palou, Joan

January 2015

The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critic...

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients

Gontero, P.
Sylvester, R.
Pisano, F.
Joniau, S.
Vander Eeckt, K.
Serretta, V.
Larré, S.
Di Stasi, S.
Van Rhijn, B.
Witjes, Aj
Grotenhuis, Aj
Kiemeney, La
Colombo, R.
Briganti, A.
Babjuk, M.
Malmström, Pu
Oderda, Marco
Irani, J.
Malats, N.
Baniel, J.
Mano, R.
Cai, T.
Cha, Ek
Ardelt, P.
Varkarakis, J.
Bartoletti, R.
Spahn, M.
Johansson, R.
Frea, B.
Soukup, V.
Xylinas, E.
Dalbagni, G.
Karnes, Rj
Shariat, Sf
Palou, J.

January 2015

BACKGROUND: The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patien...

Prognostic Factors and Risk Groups in T1G3 Non\u2013Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Gue\ub4 rin: Results of a retrospective Multicenter Study of 2451 Patients

Gontero, P
Sylvester, R
Pisano, F
Joniau, S
Eeckt, KV
Serretta, V
Larr\ue9, S
Di Stasi, S
Van Rhijn g, B
Witjes, AJ
Grotenhuis, AJ
Kiemeney, LA
Colombo, R
Alberto Briganti, A
Babjuk , M
Malmstrom, PU
, Oderda, M
Irani, J
Nuria Malats, N
Baniel, J
Mano, R
Cai, T
Cha, EK
Ardelt, P
Varkarakis, J
Bartoletti, R
Spahn, M
Johansson, R
Frea , B
Soukup, V
Xylinas, E
Dalbagni, G
Karnes RJ
Shariat SF
, Palou, J

January 2015

Background: The impact of prognostic factors in T1G3 non\u2013muscle-invasive bladder cancer (BCa) p...

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Joseph Plasek
John Weissert
Tracy Downs
Kyle Richards
Kourosh Ravvaz

June 2021

BackgroundBacillus Calmette-Guérin (BCG) is currently the most clinically effective intravesical tre...

Survival risk factors in T1G3 non-muscle-invasive (NMI) bladder cancer consevatively treated. Long term results.

Serretta, V.
Allegro, R.
Ruggirello, A.
Coraci, G.
DI DIO, M.
PAVONE MACALUSO, M.
Aragona, F.
Melloni, D.

January 2008

Introduction: The most relevant risk factor in T1G3 NMI transitional cell carcinoma of the bladder ...

Survival risk factors in T1G3 non-muscle-invasive (NMI) bladder cancer consevatively treated. Long term results.

SERRETTA, Vincenzo
ALLEGRO, Rosalinda
CORACI, Giuseppe
DI DIO, Michele
MELLONI, Darvinio
RUGGIRELLO A
PAVONE MACALUSO M
ARAGONA F

January 2008

Introduction: The most relevant risk factor in T1G3 NMI transitional cell carcinoma of the bladder...

Prognostic factors and risk groups in T1G3 non-muscle invasive bladder cancer patients initially treated with Bacillus Calmette Guerin results of a retrospective multi center study on 2451 patients

Gontero P
Sylvester R
Pisano F
Joniau S
Vander Eeckt K
Serretta V
Larré S
Di Stasi S
Van Rhijn B
Witjes AJ
Grotenhuis AJ
Kiemeney LA
Colombo R
Briganti A
Babjuk M
Malmström PU
Oderda M
Irani J
Malats N
Baniel J
Mano R
Cai T
Cha EK
Ardelt P
Varkarakis J
BARTOLETTI, RICCARDO
Spahn M
Johansson R
Frea B
Soukup V
Xylinas E
Dalbagni G
Karnes RJ
Shariat SF
Palou J.

January 2015

The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critic...

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Abstract

Extracted data

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Abstract

Extracted data

Related items

Related items